SCN9A and hereditary sensory and autonomic neuropathy: To summarize, we have undertaken a detailed assessment of the clinical phenotype of CIP due to SCN9A mutations as well as investigating the impact of these mutations on both cellular models and the somatosensory nervous system in vivo.